Last updated on November 2018

A PROSPECTIVE OBSERVATIONAL STUDY OF ADULT PATIENTS RECEIVING DUPIXENT® FOR ATOPIC DERMATITIS (registry study)


Brief description of study

This registry aims to characterize the patients who receive DUPIXENT for atopic dermatitis (AD) in a real world setting, with respect to their medical history, socio-demographic and disease characteristics, and prior and concomitant treatments of AD.

Clinical Study Identifier: TX205370

Contact Investigators or Research Sites near you

Start Over

Sadick Research Group

New York, NY United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.